Home page > Europe and Health

14/10/2014

[Joint press statement] Stoiber prescribing the wrong medicine

14 October 2014, Brussels - . The European Commission’s High Level Group on Administrative Burdens (1), chaired by Dr Edmund Stoiber, has drawn severe criticism from 4 of a total of 15 Members (2) for its final report (3) pushing an outdated, deregulatory agenda. Almost one third of ‘Stoiber group’ members oppose biased final report The views of members representing trade unions, environmental groups, consumer organisations and health groups are presented in a (...)
10/10/2014

EPHA statement on the return of pharmaceutical and medical devices to the health department of the EU

October 10th 2014, Brussels – According to statements by both the S&D (1) and Green Groups (2) yesterday, it seems likely that President-elect Jean-Claude Juncker is intending to soften his decision to move pharmaceutical policy from the health portfolio to enterprise. EPHA welcomes this news as a step in the right direction and a possible cause for celebration for the European Parliament (3) and the public health community (4). “I would like to applaud President-elect (...)
7/10/2014

[Evaluation] Hungarian Candidate Commissioner Candidate Navracsics Rejected for his Portfolio

After the Hearing of the Hungarian Commissioner Candidate Tibor Navracsics, the European Parliament Committee on Culture and Education rejected him, for the nominated portfolio - Education, Culture, Youth and Citizenship - while confirming him, as a Commissioner. This move is a result of controversial policies in Hungary with regard to civil society, media freedom and respect of Fundamental Rights and the rule of law. The inevitable reshuffle of the Commission provides for a next round of (...)
3/10/2014

[Evaluation] European Parliament hearing - Elzbieta Bienkowska European Commissioner-designate for Internal Market, Industry, Entrepreneurship and SMEs

“Placing pharma policy in DG Enterprise was justified. It has traditionally been in DG Enterprise, but was moved to DG Sanco and has once again been instated as an Enterprise competence” said during her hearing Commissioner-designate Elzbieta Bienkowska. By Dorota Sienkiewicz,Health Equity and Policy Coherence Coordinator, and Martyna Giedrojć, EPHA Policy Officer for Health Systems The pharmaceutical industry is the biggest sector in the world. In terms of production, (...)
2/10/2014

[Open letter] To Heads of State and Government of the European Union Member States on Pharmaceutical Policy in the Public Interest

Brussels, 2 October 2014 - We are writing to support Member States who have already expressed their concerns on the decision of European Commission President Elect Jean-Claude Juncker to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of Internal Market and Industry within the new Commission. We would like to ask for your full support to have that decision reversed. Dear Head of States, Dear Prime (...)
1/10/2014

[Evaluation] European Parliament hearing - Vytenis Andriukaitis European Commissioner-designate for Health and Food Safety

1 October 2014, Brussels - By European Parliament standards, Commissioner-designate Vytenis Andriukaitis’ performance could be judged to be “satisfactory”. He showed his commitment to protect European citizens’ health and well-being, and improve underlying determinants of health and physical environment. Now we will really have to see how he intends to turn words into concrete action. He was very outspoken on the issues of prevention, promotion and protection of (...)
30/09/2014

[Press release] EPHA urges European Parliament to reject moving EU pharma policy to enterprise portfolio

September 29 2014, Brussels - When questioning the EU Commissioners-designate this week, Members of the European Parliament (MEPs) should reject the decision by Jean-Claude Juncker, the European Commission President-elect, to move pharmaceutical policy from the health to the enterprise portfolio (1). The main driver of EU policies concerning pharmaceuticals and health technologies should be promoting and protecting health and patient safety, not simply boosting the competitiveness of the (...)
1/10/2014

EPHA profiles of European Commissioners-designate key for public health

Vytenis Andriukaitis - European Commissioner-designate for Health and Food Safety Elżbieta Bieńkowska » European Commissioner-designate for Internal Market, Industry, Entrepreneurship and SMEs Cecilia Malmström » European Commissioner-designate for Trade Pierre Moscovici » Commissioner-designate for Economic and Financial Affairs, Taxation and Customs Phil Hogan » European Commissioner-designate for Agriculture Marianne Thyssen » European Commissioner-designate for (...)
5/10/2014

Cecilia Malmström » European Commissioner-designate for Trade

From 1 November 2014, Cecilia Malmström will take office as the new Commissioner for Trade, under the Juncker Commission. The appointment of Swedish native Ms. Malmstrom implies that the President-elect of the European Commission, Jean-Claude Juncker, would like to further promote discussion with the U.S. on the much debated Transatlantic Trade and Investment Partnership (TTIP). By Leonardo Palumbo, EPHA Policy Coordinator for EU Affairs and Arthur Matthews, Policy Assistant As (...)
5/10/2014

Marianne Thyssen » European Commissioner-designate for Employment, Social Affairs, Skills and Labour Mobility

For the crucial Commissioner portfolio comprising Employment, Social Affairs, Skills and Labour Mobility, President-elect Jean-Claude Juncker has nominated Marianne Thyssen from Belgium. As part of her designated responsibilities, Ms Thyssen’s responsibilities will include issues related to the free movement of workers and migration, skills development and promotion of lifelong learning, to ensure that European labour markets are able to deliver jobs and growth. By Sascha Marschang, (...)

0 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | ...